Seems like the folks running this company are going to burn through cash at an alarming rate. Startup pharmas are huge risks -- and lightning rarely strikes twice. From what I understand, they are going to need more cash infusions. Seems like a very risky play unless you take your profits now - if you can. Perhaps they are already shopping themselves around -- any word??